Biogen (BIIB) shares outstanding

Shares outstanding · fiscal 2025
147.10M

Biogen (BIIB) had 147.10M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.8% higher than the 145.90M of fiscal 2024. Figures as of 18 Nov 2026, 12:18 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
147.10M
Change on fiscal 2024
+0.8%
Growth, 5 years
−1.8% a year
Growth, 10 years
−4.4% a year
Highest on record
320.17Mfiscal 2007
Lowest on record
145.60Mfiscal 2023
Fiscal years on record
192007–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Biogen shares outstanding, in more detail

The market data feed counts 147.82M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count shrank at a compound 1.8% a year; over ten years the rate was −4.4% a year. Across the 19 fiscal years on record (2007–2025), the highest was 320.17M in fiscal 2007 and the lowest 145.60M in fiscal 2023.

History · 19 fiscal years

Shares outstanding by fiscal year

Biogen shares outstanding, year by year

Biogen (BIIB) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025147.10M 0.8% up
2024145.90M 0.2% up
2023145.60M 0.3% down
2022146.00M 2.4% down
2021149.60M 7.3% down
2020161.30M 13.9% down
2019187.40M 8.7% down
2018205.30M 3.6% down
2017213.00M 2.7% down
2016218.80M 5.4% down
2015231.20M 2.5% down
2014237.20M 0.5% down
2013238.30M 0.6% down
2012239.74M 2.2% down
2011245.03M 3.9% down
2010254.87M 12.0% down
2009289.48M 1.9% down
2008294.98M 7.9% down
2007320.17M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Biogen and comparable companies
CompanyShares outstandingFiscal year
Royalty Pharma RPRX564.46M2025
Biogen BIIB147.10M2025
GE HealthCare Technologies GEHC458.00M2025
Alcon ALC496.20M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BIIB

Biogen, figure by figure

Biogen (BIIB) overview: price, valuation and scorecardAll health care companies by market value

Biogen shares outstanding: questions and answers

How many shares does Biogen have?

Biogen (BIIB) had 147.10M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.8% higher than the 145.90M of fiscal 2024. The market data feed counts 147.82M shares outstanding today.

What is the growth rate of Biogen's diluted share count?

Over the five fiscal years to 2025 the diluted share count shrank at a compound 1.8% a year; over ten years the rate was −4.4% a year.

What are the highest and lowest diluted share count figures on record for Biogen?

Across the 19 fiscal years on record (2007–2025), the highest was 320.17M in fiscal 2007 and the lowest 145.60M in fiscal 2023.

How is Biogen's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Biogen it is on record here for 19 fiscal years, 2007 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Biogen (BIIB) shares outstanding”, data as of 18 November 2026. https://funkfolio.com/stock/BIIB/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.